Biologics Regulatory Spine BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergNovember 17, 2025
Biologics Spine Top Stories Aurora Spine Launches New Biologics Portfolio byTim AllenOctober 27, 2025
Biologics Regulatory FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions byJosh SandbergJanuary 6, 2025
Biologics Extremities Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio byJosh SandbergNovember 14, 2023
Biologics Spine Top Stories HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation byJosh SandbergSeptember 6, 2023
Biologics Spine Spine Biologics Market to hit USD 3.4 billion by 2032, says Global Market Insights Inc. byJosh SandbergAugust 29, 2023
Biologics Spine Top Stories Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business byJosh SandbergAugust 10, 2023
Biologics Spine Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics Business byJosh SandbergJuly 28, 2023
Biologics Top Stories HippoFi’s PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States byJosh SandbergJune 28, 2023
Biologics Financial Spine Spine Biologics Market to Surpass USD 3.5 billion in 2033, expected to expand at a 4.2% CAGR: TMR Report byJosh SandbergJune 19, 2023
